Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe.

Varas-Lorenzo C, García-Rodríguez LA, Cattaruzzi C, Troncon MG, Agostinis L, Perez-Gutthann S.

Am J Epidemiol. 1998 Feb 15;147(4):387-90.

2.

Hormone therapy and risk of venous thromboembolism among postmenopausal women.

Canonico M, Scarabin PY.

Climacteric. 2009;12 Suppl 1:76-80. Review.

PMID:
19811247
3.

Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.

Oger E, Scarabin PY.

Drugs Aging. 1999 Jan;14(1):55-61. Review.

PMID:
10069408
4.

Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.

Miller J, Chan BK, Nelson HD.

Ann Intern Med. 2002 May 7;136(9):680-90. Review. Erratum in: Ann Intern Med. 2003 Feb 18;138(4):360..

PMID:
11992304
5.

[Hormone therapy and risk for venous thromboembolism in postmenopausal women].

Lacut K, Oger E.

Rev Prat. 2005 Feb 28;55(4):389-92. Review. French.

PMID:
15828617
6.

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY.

BMJ. 2008 May 31;336(7655):1227-31. doi: 10.1136/bmj.39555.441944.BE. Epub 2008 May 20. Review.

7.
8.

[Hormone replacement therapy in menopause and risk of breast cancer].

Clavel-Chapelon F, Hill C.

Presse Med. 2000 Oct 21;29(31):1688-93. Review. French.

PMID:
11094609
9.

Postmenopausal hormone replacement therapy and venous thromboembolism.

Wu O.

Gend Med. 2005;2 Suppl A:S18-27. Review.

PMID:
16551553
10.

[The risk of venous thromboembolism in women during hormone replacement therapy].

Zeltzer D, Shapira I, Berliner S.

Harefuah. 1999 Aug;137(3-4):124-6. Review. Hebrew. No abstract available.

PMID:
10959301
11.

Venous thrombo-embolism and hormone replacement therapy.

Whitehead M, Godfree V.

Baillieres Clin Obstet Gynaecol. 1997 Sep;11(3):587-99. Review.

PMID:
9488793
12.

[Estrogen therapy and venous thromboembolic disease].

Lévesque H, Courtois H.

Rev Med Interne. 1997;18 Suppl 6:620s-625s. Review. French.

PMID:
9515142
13.

Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.

Olié V, Canonico M, Scarabin PY.

Curr Opin Hematol. 2010 Sep;17(5):457-63. doi: 10.1097/MOH.0b013e32833c07bc. Review.

PMID:
20601871
14.

Hormone therapy and thromboembolic disease.

Battaglioli T, Martinelli I.

Curr Opin Hematol. 2007 Sep;14(5):488-93. Review.

PMID:
17934355
15.

Hormone replacement therapy and venous thromboembolism.

Greer IA, Walker ID.

Climacteric. 1999 Sep;2(3):224-31. Review. No abstract available.

PMID:
11910601
16.

Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.

Rekers H, Norpoth T, Michaels MA.

Eur J Contracept Reprod Health Care. 1996 Mar-May;1(1):21-30. Review.

PMID:
9678134
17.

HRT and the risk of deep vein thrombosis.

Barlow DH.

Int J Gynaecol Obstet. 1997 Oct;59 Suppl 1:S29-33. Review.

PMID:
9386213
18.

[Effects of hormone replacement treatment of menopause on the risk of venous thromboembolic disease].

Thery C, Prat A, Asseman P, Bauchart JJ, Michon P, Lesenne M, Jude B.

Therapie. 1997 May-Jun;52(3):165-8. Review. French.

PMID:
9366099
19.

Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review.

Castellsague J, Pérez Gutthann S, García Rodríguez LA.

Drug Saf. 1998 Feb;18(2):117-23. Review.

PMID:
9512918
20.

Hormone therapies and venous thromboembolism: where are we now?

van Hylckama Vlieg A, Middeldorp S.

J Thromb Haemost. 2011 Feb;9(2):257-66. doi: 10.1111/j.1538-7836.2010.04148.x. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk